[
  {
    "ts": null,
    "headline": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today",
    "summary": "Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=ee95621a3c1b1409300a23b4216248bc7eee413b32cd4714c4e007873e41b9b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741902616,
      "headline": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today",
      "id": 133185494,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=ee95621a3c1b1409300a23b4216248bc7eee413b32cd4714c4e007873e41b9b5"
    }
  },
  {
    "ts": null,
    "headline": "CRISPR Therapeutics: An Uninspiring Start For Casgevy",
    "summary": "CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious \"Hold\" within a barbell portfolio.",
    "url": "https://finnhub.io/api/news?id=774ffbfb9ba9f0ea1819e4599c214d421107e388e57de809a7ebbbf22c59949c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741898461,
      "headline": "CRISPR Therapeutics: An Uninspiring Start For Casgevy",
      "id": 133165247,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/113456532/image_113456532.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious \"Hold\" within a barbell portfolio.",
      "url": "https://finnhub.io/api/news?id=774ffbfb9ba9f0ea1819e4599c214d421107e388e57de809a7ebbbf22c59949c"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=7c6bf6e192184476551cf2b1450f4874e42712addcf34e64ca07ba2b64d4f0d7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741883820,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 133172975,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=7c6bf6e192184476551cf2b1450f4874e42712addcf34e64ca07ba2b64d4f0d7"
    }
  },
  {
    "ts": null,
    "headline": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
    "summary": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=525462baf97cedb30694019df10579d06c99d166a081e7f12a22589e2e566f2e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741880408,
      "headline": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
      "id": 133185354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=525462baf97cedb30694019df10579d06c99d166a081e7f12a22589e2e566f2e"
    }
  }
]